| 30/01/25 | 07:00:07 | 30 Jan 2025 | | Offer Update - Extension to PUSU Deadline | RNS |
| 17/01/25 | 18:25:00 | 17 Jan 2025 | | Replacement - Form 8.3 - Poolbeg Pharma plc | RNS |
| 17/01/25 | 11:27:09 | 17 Jan 2025 | | Form 8.3 - Poolbeg Pharma plc | RNS |
| 16/01/25 | 13:53:14 | 16 Jan 2025 | | Form 8.3 - Poolbeg Pharma plc | RNS |
| 15/01/25 | 18:04:08 | 15 Jan 2025 | | Form 8.3 - Poolbeg Pharma plc | RNS |
| 14/01/25 | 17:33:13 | 14 Jan 2025 | | Form 8.3 - Poolbeg Pharma plc | RNS |
| 14/01/25 | 17:32:15 | 14 Jan 2025 | | Form 8.3 - Poolbeg Pharma plc | RNS |
| 13/01/25 | 18:28:44 | 13 Jan 2025 | | Form 8.3 - Poolbeg Pharma plc | RNS |
| 10/01/25 | 07:00:04 | 10 Jan 2025 | | Update Potential Combination of Poolbeg & HOOKIPA | RNS |
| 09/01/25 | 07:00:06 | 9 Jan 2025 | | Holding(s) in Company | RNS |
| 08/01/25 | 15:53:58 | 8 Jan 2025 | | Form 8 (OPD) - Poolbeg Pharma plc | RNS |
| 07/01/25 | 07:00:05 | 7 Jan 2025 | | Update Potential Combination of Poolbeg & HOOKIPA | RNS |
| 02/01/25 | 07:00:06 | 2 Jan 2025 | | Combination of Poolbeg and HOOKIPA Pharma Inc. | RNS |
| 09/12/24 | 07:00:07 | 9 Dec 2024 | | Poolbeg presents POLB 001 data at 66th ASH Meeting | RNS |
| 20/11/24 | 07:00:02 | 20 Nov 2024 | | POLB 001 Patent Granted in United States | RNS |
| 06/11/24 | 07:00:08 | 6 Nov 2024 | | POLB 001 data to be presented at ASH | RNS |
| 18/09/24 | 07:00:04 | 18 Sept 2024 | | Interim results for the six months to 30 June 2024 | RNS |
| 27/08/24 | 07:00:14 | 27 Aug 2024 | | H.C. Wainwright Global Investment Conference | RNS |
| 12/08/24 | 13:28:40 | 12 Aug 2024 | | Holding(s) in Company | RNS |
| 26/07/24 | 07:00:05 | 26 Jul 2024 | | Voluntary Delisting from OTCQB Market | RNS |
| 10/07/24 | 07:00:09 | 10 Jul 2024 | | Notification of Major Holdings | RNS |
| 02/07/24 | 07:00:09 | 2 Jul 2024 | | Change of Registered Address | RNS |
| 17/06/24 | 08:38:38 | 17 Jun 2024 | | Result of AGM | RNS |
| 09/05/24 | 07:00:06 | 9 May 2024 | | Annual Report & AGM Notice | RNS |
| 01/05/24 | 07:00:08 | 1 May 2024 | | Significant POLB 001 Patent Granted in USA | RNS |
| 30/04/24 | 07:02:00 | 30 Apr 2024 | | Appointment of Joint Broker | RNS |
| 30/04/24 | 07:01:00 | 30 Apr 2024 | | Option Agreement to Acquire Orphan Drug Candidate | RNS |
| 30/04/24 | 07:00:11 | 30 Apr 2024 | | Results for the year ended 31 December 2023 | RNS |
| 29/04/24 | 07:00:12 | 29 Apr 2024 | | TR-1: Notification of major holdings | RNS |
| 20/03/24 | 07:00:04 | 20 Mar 2024 | | POLB 001 US Patent Update | RNS |
| 22/02/24 | 07:00:09 | 22 Feb 2024 | | Director/PDMR Shareholding | RNS |
| 19/02/24 | 13:42:01 | 19 Feb 2024 | | Director Share Purchase | RNS |
| 15/02/24 | 07:00:06 | 15 Feb 2024 | | Board Role Change and Launch of EIP | RNS |
| 12/02/24 | 07:00:07 | 12 Feb 2024 | | Market Opportunity for POLB 001 for CRS | RNS |
| 17/01/24 | 07:00:05 | 17 Jan 2024 | | Further data shows POLB001 potential in cancer CRS | RNS |
| 20/12/23 | 07:00:12 | 20 Dec 2023 | | RSV AI Drug Candidate Analysis Update | RNS |
| 11/12/23 | 07:00:07 | 11 Dec 2023 | | POLB 001 Data Presented at ASH | RNS |
| 30/11/23 | 07:00:16 | 30 Nov 2023 | | Directorate Change | RNS |
| 21/11/23 | 07:00:13 | 21 Nov 2023 | | Immunomodulator II patent granted in Japan | RNS |
| 16/11/23 | 07:00:15 | 16 Nov 2023 | | POLB 001 LPS Trial Data to be Presented at IUIS | RNS |
| 09/11/23 | 07:00:15 | 9 Nov 2023 | | Former Amryt Pharma Leadership Team join Poolbeg | RNS |
| 03/11/23 | 07:05:48 | 3 Nov 2023 | | POLB001 Data to be Presented at ASH Annual Meeting | RNS |
| 01/11/23 | 07:00:10 | 1 Nov 2023 | | POLB 001 Oncology Programme Update Meeting | RNS |
| 26/10/23 | 07:00:14 | 26 Oct 2023 | | SAB Endorses Influenza Drug Targets | RNS |
| 17/10/23 | 07:00:09 | 17 Oct 2023 | | Poolbeg Partners with a Nasdaq-Listed Biopharma | RNS |
| 29/09/23 | 07:00:12 | 29 Sept 2023 | | Favourable Conclusion of Patent Opposition | RNS |
| 20/09/23 | 07:00:10 | 20 Sept 2023 | | Immunomodulator I Patent Portfolio Strengthened | RNS |
| 19/09/23 | 07:00:04 | 19 Sept 2023 | | Immunomodulator I Patent Opposition Withdrawal | RNS |
| 13/09/23 | 07:00:04 | 13 Sept 2023 | | Interim results for the six months to 30 June 2023 | RNS |
| 29/06/23 | 07:00:02 | 29 Jun 2023 | | AI led programme identifies influenza drug targets | RNS |
